Generex Biotechnology Corp. (fka GNBTQ)

[namtae]

Thank you

What's very confusing is the piece current shareholders will receive from the NGIO spinoff.

I noticed a long, drawn out Q&A of asking just that question with confusing answers. Which is why the questioner rightly asked the same question 5 different ways trying to understand just what the ceo was saying.

Im not sure anyone relying on what the transcript read, knows the answer.

Originally, I thought current shareholders were to receive 10%, then I read 6%, then what about this or that organization, do they get a piece blah blah blah

Confusing to say the least. I think if the company provided a cap table for NGIO and expected or planned for issuance's, it might shed some light. At least I give them credit for including the Q&A in the transcript... finally